Health IT

Big Pharma is pouring over $1 billion into AI to design complex drugs, trading lab guesswork for algorithms. It's a high-stakes play to fix a broken R&D model.

Kimberly-Clark's new campaign with Deion Sanders is more than a celebrity deal; it's a strategic masterclass in using raw authenticity to disrupt a silent market.

Restore Hyper Wellness is using a gamified challenge to keep clients engaged this summer. But is this a new frontier in personal resilience or just savvy marketing?

A small-town medical spa is investing in cutting-edge tech for body, bladder, and brain. Is this the future of healthcare or a high-stakes gamble?

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

Elevance Health is deploying a suite of AI-driven tools to manage chronic illness. Is this the future of healthcare or just a new set of digital hurdles?

A French medtech firm is deploying a non-invasive ultrasound device that repairs heart valves, creating a new market for patients too frail for surgery.

Replacing your home's siding is more than a cosmetic upgrade. Experts warn that skipping a crucial inspection can lead to costly structural damage and energy loss.

While a local Indiana story highlights the human cost of caregiver burnout, it unveils a massive, underserved market poised for explosive growth and fintech innovation.

A landmark study proves drones can safely transport human kidneys, a breakthrough that could slash wait times and save lives. But can we clear the regulatory hurdles?

BVI's new European training hub isn't just a facility; it's a response to a critical skills gap in medicine, revealing how industry is shaping our trust in healthcare.

Highwire appoints veteran CFO Kelly Losko, a move that caps a period of intense growth, including a major acquisition and the launch of its proprietary AI platform.

The financial giant extends its massive Security and Resiliency Initiative north, targeting defense, energy, and supply chains to bolster regional stability.

With a $50M seed round, Radical Numerics aims to build general biological intelligence, walking a fine line between curing disease and creating bioweapons.

With projections of $22.7M from four new supplements, Cosmos Health is betting big on the US. But can its 'science-driven' platform deliver in a crowded market?

New data reveals upstream patient guidance slashes surgical costs, challenging the old guard of healthcare management and signaling a new era of digital-first care.

As Orca Bio builds a manufacturing empire from Sacramento to Princeton, it's not just preparing for a new drug launch—it's trying to solve the biggest puzzle in biotech.

A new strategic alliance between a pharma giant and a leading non-profit is deploying a $20M plan to close the deadly prostate cancer survival gap.

Ottawa is set to unveil a new law for First Nations water, but after decades of broken promises, will this legislation finally deliver or just be another drop in the bucket?

A 23% national drop in overdose deaths signals progress, but regional disparities and a volatile drug supply show the fight is far from over.